1. Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA 2. Comprehensive Diabetes Center, University of Alabamaat Birmingham, Birmingham, AL, USA 3. Department of ...
CHICAGO — Ten people with type 1 diabetes, who had recurrent severe hypoglycemia and hypoglycemic unawareness, have remained insulin-independent for over a year following allogeneic stem cell-derived ...
SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing ...
NEW YORK, USA, August 21, 2023/EINPresswire.com/ -- Altucell Therapeutics is making monumental advancements in the realm of diabetes care. The company remains at the ...
Oral presentations were held at the congresses of the ADA1, EASD2 and IPITA-IXA-CTRMS3 Evidence support that AdoShell® Islets is a scalable biocompatible immunoprotective biomaterial for islet ...
Since the 1960s, researchers have been interested in the possibility of treating type 1 diabetes by transplanting islet cells -- the pancreatic cells that are responsible for producing insulin when ...
Doctoral students Alan Chiu, left, and Duo An hold a sample of TRAFFIC (Thread-Reinforced Alginate Fiber for Islets enCapsulation). In the background, left to right, are Minglin Ma, Dan Luo, Meredith ...
ORLANDO, Fla — Stem cell–derived beta-cell replacement therapy continues to show benefit in people with type 1 diabetes at a high risk for severe hypoglycemia. Of a total 17 patients who received a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results